Mesoblast Ltd Files 6-K with ASX Announcements
Ticker: MEOBF · Form: 6-K · Filed: Aug 29, 2025 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Aug 29, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, announcement, investor-presentation
TL;DR
MESO dropped a 6-K with ASX news & investor deck on 8/29.
AI Summary
On August 29, 2025, Mesoblast Limited filed a Form 6-K with the SEC, attaching a new release announcement and investor presentation. The company, incorporated in Australia, is a foreign private issuer and files annual reports under Form 20-F. Its principal executive offices are located at Level 38, 55 Collins Street, Melbourne, Victoria, 3000.
Why It Matters
This filing indicates Mesoblast Limited is providing updated information to the market, which could impact investor decisions regarding the company's stock.
Risk Assessment
Risk Level: low — This is a routine filing of publicly available information from the Australian Securities Exchange.
Key Players & Entities
- MESOBLAST LTD (company) — Registrant
- August 29, 2025 (date) — Filing Date
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- Melbourne, Victoria (location) — Principal Executive Offices
- 001-37626 (other) — Commission File Number
FAQ
What type of information is Mesoblast Limited providing in this Form 6-K?
Mesoblast Limited is providing a new release announcement and investor presentation, filed with the Australian Securities Exchange.
When was this Form 6-K filed?
The Form 6-K was filed on August 29, 2025.
What is Mesoblast Limited's jurisdiction of incorporation?
Mesoblast Limited is incorporated in Australia.
Who is the Chief Executive Officer and Executive Director of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
Does Mesoblast Limited file annual reports under Form 20-F or Form 40-F?
Mesoblast Limited files annual reports under Form 20-F.
Filing Stats: 228 words · 1 min read · ~1 pages · Grade level 14.7 · Accepted 2025-08-29 06:58:36
Filing Documents
- a2025-08x29annualfinancial.htm (6-K) — 16KB
- exhibit991.htm (EX-99.1) — 31KB
- exhibit992.htm (EX-99.2) — 35KB
- exhibit991001.jpg (GRAPHIC) — 227KB
- exhibit991002.jpg (GRAPHIC) — 220KB
- exhibit991003.jpg (GRAPHIC) — 299KB
- exhibit991004.jpg (GRAPHIC) — 246KB
- exhibit991005.jpg (GRAPHIC) — 273KB
- exhibit991006.jpg (GRAPHIC) — 225KB
- exhibit991007.jpg (GRAPHIC) — 125KB
- exhibit991008.jpg (GRAPHIC) — 123KB
- exhibit991009.jpg (GRAPHIC) — 125KB
- exhibit992001.jpg (GRAPHIC) — 68KB
- exhibit992002.jpg (GRAPHIC) — 155KB
- exhibit992003.jpg (GRAPHIC) — 81KB
- exhibit992004.jpg (GRAPHIC) — 116KB
- exhibit992005.jpg (GRAPHIC) — 106KB
- exhibit992006.jpg (GRAPHIC) — 109KB
- exhibit992007.jpg (GRAPHIC) — 126KB
- exhibit992008.jpg (GRAPHIC) — 112KB
- exhibit992009.jpg (GRAPHIC) — 89KB
- exhibit992010.jpg (GRAPHIC) — 104KB
- exhibit992011.jpg (GRAPHIC) — 134KB
- exhibit992012.jpg (GRAPHIC) — 81KB
- exhibit992013.jpg (GRAPHIC) — 151KB
- exhibit992014.jpg (GRAPHIC) — 131KB
- exhibit992015.jpg (GRAPHIC) — 96KB
- exhibit992016.jpg (GRAPHIC) — 106KB
- exhibit992017.jpg (GRAPHIC) — 115KB
- exhibit992018.jpg (GRAPHIC) — 179KB
- exhibit992019.jpg (GRAPHIC) — 87KB
- exhibit992020.jpg (GRAPHIC) — 142KB
- exhibit992021.jpg (GRAPHIC) — 119KB
- exhibit992022.jpg (GRAPHIC) — 211KB
- exhibit992023.jpg (GRAPHIC) — 68KB
- exhibit992024.jpg (GRAPHIC) — 123KB
- exhibit992025.jpg (GRAPHIC) — 104KB
- exhibit992026.jpg (GRAPHIC) — 131KB
- exhibit992027.jpg (GRAPHIC) — 72KB
- exhibit992028.jpg (GRAPHIC) — 145KB
- exhibit992029.jpg (GRAPHIC) — 152KB
- exhibit992030.jpg (GRAPHIC) — 129KB
- exhibit992031.jpg (GRAPHIC) — 144KB
- exhibit992032.jpg (GRAPHIC) — 143KB
- exhibit992033.jpg (GRAPHIC) — 62KB
- exhibit992034.jpg (GRAPHIC) — 122KB
- exhibit992035.jpg (GRAPHIC) — 37KB
- 0001345099-25-000068.txt ( ) — 8229KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Niva Sivakumar Niva Sivakumar Company Secretary Dated August 29, 2025 INDEX TO EXHIBITS Item 99.1 Press release of Mesoblast Ltd, dated August 29, 2025 . 99.2 Investor presentation of Mesoblast Ltd, dated August 29, 2025.